[go: up one dir, main page]

SI2448950T1 - Sinteza N4-(2,2-dimetil-4-((dihidrogen fosfonoksi)metil)-3-okso-5-pirido(1,4)oksazin-6-il)-5-fluoro-N2-(3,4,5- trimetoksifenil)-2,4-pirimidindiamin dinatrijeve soli - Google Patents

Sinteza N4-(2,2-dimetil-4-((dihidrogen fosfonoksi)metil)-3-okso-5-pirido(1,4)oksazin-6-il)-5-fluoro-N2-(3,4,5- trimetoksifenil)-2,4-pirimidindiamin dinatrijeve soli

Info

Publication number
SI2448950T1
SI2448950T1 SI201031148A SI201031148A SI2448950T1 SI 2448950 T1 SI2448950 T1 SI 2448950T1 SI 201031148 A SI201031148 A SI 201031148A SI 201031148 A SI201031148 A SI 201031148A SI 2448950 T1 SI2448950 T1 SI 2448950T1
Authority
SI
Slovenia
Prior art keywords
oxazin
trimethoxyphenyl
pyrido
oxo
fluoro
Prior art date
Application number
SI201031148A
Other languages
English (en)
Inventor
Ulfried Felfer
Karl-Heinz Giselbrecht
Michael Wolberg
Original Assignee
Rigel Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals, Inc. filed Critical Rigel Pharmaceuticals, Inc.
Publication of SI2448950T1 publication Critical patent/SI2448950T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI201031148A 2009-07-02 2010-07-01 Sinteza N4-(2,2-dimetil-4-((dihidrogen fosfonoksi)metil)-3-okso-5-pirido(1,4)oksazin-6-il)-5-fluoro-N2-(3,4,5- trimetoksifenil)-2,4-pirimidindiamin dinatrijeve soli SI2448950T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27007309P 2009-07-02 2009-07-02
EP10730679.7A EP2448950B1 (en) 2009-07-02 2010-07-01 Synthesis of n4-(2,2-dimethyl-4-[(dihydrogen phosphonoxy)methyl]-3-oxo-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine disodium salt
PCT/US2010/040792 WO2011002999A1 (en) 2009-07-02 2010-07-01 Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt

Publications (1)

Publication Number Publication Date
SI2448950T1 true SI2448950T1 (sl) 2016-05-31

Family

ID=42937685

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201031148A SI2448950T1 (sl) 2009-07-02 2010-07-01 Sinteza N4-(2,2-dimetil-4-((dihidrogen fosfonoksi)metil)-3-okso-5-pirido(1,4)oksazin-6-il)-5-fluoro-N2-(3,4,5- trimetoksifenil)-2,4-pirimidindiamin dinatrijeve soli

Country Status (21)

Country Link
US (3) US8299242B2 (sl)
EP (1) EP2448950B1 (sl)
JP (1) JP5739882B2 (sl)
CN (1) CN102482305B (sl)
AU (1) AU2010266213B2 (sl)
BR (1) BRPI1011888A2 (sl)
CA (1) CA2766801C (sl)
CY (1) CY1117489T1 (sl)
DK (1) DK2448950T3 (sl)
EA (1) EA021657B1 (sl)
ES (1) ES2565985T3 (sl)
HR (1) HRP20160319T1 (sl)
HU (1) HUE027212T2 (sl)
ME (1) ME02388B (sl)
PL (1) PL2448950T3 (sl)
RS (1) RS54679B1 (sl)
SG (1) SG176799A1 (sl)
SI (1) SI2448950T1 (sl)
SM (1) SMT201600084B (sl)
UA (1) UA108077C2 (sl)
WO (1) WO2011002999A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8318720B2 (en) 2006-07-20 2012-11-27 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as Fab I inhibitors
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
AU2011218805A1 (en) * 2010-02-24 2012-08-30 Auspex Pharmaceuticals, Inc. Trimethoxyphenyl inhibitors of tyrosine kinase
HRP20190186T4 (hr) * 2011-07-28 2024-12-20 Rigel Pharmaceuticals, Inc. Nove formulacije (trimetoksifenilamino)pirimidinila
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
WO2013190384A1 (en) 2012-06-19 2013-12-27 Affinium Pharmaceuticals, Inc. Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
CN102746337B (zh) * 2012-06-21 2014-12-17 成都苑东药业有限公司 一种2,4-嘧啶二胺类化合物及其制备方法
TW201410657A (zh) 2012-08-02 2014-03-16 Endo Pharmaceuticals Inc 經取代胺基-嘧啶衍生物
DK3083648T3 (en) * 2013-12-20 2019-01-07 Rigel Pharmaceuticals Inc PHARMACEUTICAL PROCEDURE AND INTERMEDIATES
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
CN110087646A (zh) 2016-09-08 2019-08-02 格利康科技集团有限责任公司 单体双金属羟基柠檬酸化合物及其制备和使用方法
US10590136B2 (en) * 2017-10-04 2020-03-17 Celgene Corporation Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
CN116327781A (zh) 2019-02-14 2023-06-27 德彪药业国际股份公司 阿法比星制剂及其制备方法
MA56184A (fr) 2019-06-14 2022-04-20 Debiopharm Int Sa Afabicine pour utilisation dans le traitement d'infections bactériennes impliquant un biofilm

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US324087A (en) 1885-08-11 Abel combs
US303022A (en) 1884-08-05 Egg-beater
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
AU2003221887A1 (en) 2002-04-12 2003-10-27 Tritek Technologies, Inc. Mail sorting processes and systems
ATE451104T1 (de) 2002-07-29 2009-12-15 Rigel Pharmaceuticals Inc Verfahren zur behandlung oder pruvention von autoimmunkrankheiten mit 2,4-pyrimidindiamin- verbindungen
ES2421139T3 (es) 2003-07-30 2013-08-29 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
US20060047135A1 (en) 2004-08-30 2006-03-02 Chadwick Scott T Process for preparing chloromethyl di-tert-butylphosphate
EP2161275A1 (en) * 2005-01-19 2010-03-10 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
CN101282979B (zh) * 2005-09-13 2011-09-21 卫材R&D管理有限公司 稳定性被改善的含有磷酸氯甲酯衍生物的组合物及其制备方法
US8163902B2 (en) * 2006-11-21 2012-04-24 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну

Also Published As

Publication number Publication date
CA2766801C (en) 2018-03-13
WO2011002999A1 (en) 2011-01-06
HUE027212T2 (en) 2016-10-28
EA201270114A1 (ru) 2012-05-30
US20130018185A1 (en) 2013-01-17
RS54679B1 (sr) 2016-08-31
US8481724B2 (en) 2013-07-09
EP2448950A1 (en) 2012-05-09
US20130274499A1 (en) 2013-10-17
JP5739882B2 (ja) 2015-06-24
US8299242B2 (en) 2012-10-30
CN102482305A (zh) 2012-05-30
HRP20160319T1 (hr) 2016-04-22
BRPI1011888A2 (pt) 2016-04-12
DK2448950T3 (en) 2016-04-04
JP2012532143A (ja) 2012-12-13
EP2448950B1 (en) 2016-01-13
US8691798B2 (en) 2014-04-08
SMT201600084B (it) 2016-04-29
CA2766801A1 (en) 2011-01-06
SG176799A1 (en) 2012-01-30
PL2448950T3 (pl) 2016-06-30
US20110003986A1 (en) 2011-01-06
CN102482305B (zh) 2016-07-13
ES2565985T3 (es) 2016-04-08
HK1169996A1 (zh) 2013-02-15
CY1117489T1 (el) 2017-04-26
UA108077C2 (xx) 2015-03-25
AU2010266213B2 (en) 2015-06-18
AU2010266213A1 (en) 2012-02-02
EA021657B1 (ru) 2015-08-31
ME02388B (me) 2016-09-20

Similar Documents

Publication Publication Date Title
SI2448950T1 (sl) Sinteza N4-(2,2-dimetil-4-((dihidrogen fosfonoksi)metil)-3-okso-5-pirido(1,4)oksazin-6-il)-5-fluoro-N2-(3,4,5- trimetoksifenil)-2,4-pirimidindiamin dinatrijeve soli
BR112012000885A2 (pt) composições de fosfito estáveis hidroliticamente.
DK3308769T3 (da) Fremgangsmåder til fremstilling af cykliske lipidimplantater til intraokulær anvendelse
BRPI0818012A2 (pt) Dispositivo de enchimento de um implante cirúrgico
BRPI0819475A2 (pt) Câmara de tratamento ultrassônico para preparar formulações antimicrobianas
BRPI1008498A2 (pt) Composto, prodroga do composto, medicamento, e, uso de um composto.
EP2066266A4 (en) POSTERIORE STABILIZED KNEE PROSTHESIS
TN2011000291A1 (en) Purine compounds
ES2590905T8 (es) Inhibidores de la tirosina quinasa de Bruton
EP2300013A4 (en) Phosphorus derivatives as kinase inhibitors
BRPI0817306A2 (pt) Implante para se ajustar dentro de um espaço intervertebral
EP2609064A4 (en) PHARMACEUTICAL COMPOSITIONS WITH POH DERIVATIVES
TN2012000392A1 (en) Oral formulations and lipophilic salts of methylnaltrexone
EP2726021A4 (en) ORTHOPEDIC PROSTHETIC ASSEMBLY WITH REAR STABILIZATION
GB0708862D0 (en) Precision weeders
IL233296B (en) Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione
GB0708861D0 (en) Precision seeders
GB201014388D0 (en) Biocompatible compositions for tissue augmentation
EA201270728A1 (ru) Пуриновые соединения
PL1864668T3 (pl) Wykorzystanie proleku do okulistycznego podawania śródszklistkowego
BR112013014485A2 (pt) composições altamente estáveis de análogos de nucleotídeos ativos por via oral ou promedicamentos de análogos de nucleotídeos ativos por via oral
EP2344503A4 (en) 5-azaindole bisphosphonates
BRPI0719791A2 (pt) Transportador de implante dentário
FR2960122B1 (fr) Machine a planter des rhizomes, et notamment des rhizomes de miscanthus
IT1400009B1 (it) Struttura di supporto per la realizzazione di strumenti per protesi dentali